Expression of p66Shc protein correlates with proliferation of human prostate cancer cells

Suresh Veeramani, Tsukasa Igawa, Ta Chun Yuan, Fen Fen Lin, Ming Shyue Lee, Jamie S. Lin, Sonny L. Johansson, Ming-Fong Lin

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

p66Shc, an isoform of Shc adaptor proteins, is shown to mediate various signals, including cellular stress. However, little is known about its involvement in carcinogenesis. We previously showed that p66Shc protein level is upregulated by steroid hormones in human carcinoma cells and is higher in prostate cancer (PCa) specimens than adjacent noncancerous cells. In this study, we investigated the role of p66Shc protein in PCa cell proliferation. Among different PCa cell lines tested, p66Shc protein level showed positive correlation with cell proliferation, that is, rapid-growing cells expressed higher p66Shc protein than slow-growing cells. Exposure of slow-growing LNCaP C-33 cells to epidermal growth factor (EGF) and 5α-dihydrotestosterone (DHT) led to upregulation of proliferation and p66Shc protein level. Conversely, growth suppression of fast-growing cells by cellular form of prostatic acid phosphatase (cPAcP) expression, a negative growth regulator, downregulated their p66 Shc protein level. Additionally, increased expression of p66 Shc protein by cDNA transfection in LNCaP C-33 cells resulted in increased cell proliferation. Cell cycle analyses showed higher percentage of p66Shc-overexpressing cells at S phase (24%) than control cells (17%), correlating with their growth rates. On the other hand, transient knock-down of p66Shc expression by RNAi in rapidly growing cells decreased their proliferation as evidenced by the reduced cell growth as well as S phase in p66Shc-knocked down cells. The p66Shc signaling in cell growth regulation is apparently mediated by extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK). Thus, our results indicate a novel role for p66Shc in prostate carcinogenesis, in part, promoting cell proliferation.

Original languageEnglish (US)
Pages (from-to)7203-7212
Number of pages10
JournalOncogene
Volume24
Issue number48
DOIs
StatePublished - Nov 3 2005

Fingerprint

Prostatic Neoplasms
Proteins
Cell Proliferation
Growth
S Phase
Shc Signaling Adaptor Proteins
Carcinogenesis
Dihydrotestosterone
Extracellular Signal-Regulated MAP Kinases
RNA Interference
Mitogen-Activated Protein Kinases
Epidermal Growth Factor
Transfection
Prostate
Cell Cycle
Protein Isoforms
Up-Regulation
Down-Regulation
Complementary DNA
Steroids

Keywords

  • Cell proliferation
  • Prostate cancer
  • Prostatic acid phosphatase
  • p66

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Veeramani, S., Igawa, T., Yuan, T. C., Lin, F. F., Lee, M. S., Lin, J. S., ... Lin, M-F. (2005). Expression of p66Shc protein correlates with proliferation of human prostate cancer cells. Oncogene, 24(48), 7203-7212. https://doi.org/10.1038/sj.onc.1208852

Expression of p66Shc protein correlates with proliferation of human prostate cancer cells. / Veeramani, Suresh; Igawa, Tsukasa; Yuan, Ta Chun; Lin, Fen Fen; Lee, Ming Shyue; Lin, Jamie S.; Johansson, Sonny L.; Lin, Ming-Fong.

In: Oncogene, Vol. 24, No. 48, 03.11.2005, p. 7203-7212.

Research output: Contribution to journalArticle

Veeramani, S, Igawa, T, Yuan, TC, Lin, FF, Lee, MS, Lin, JS, Johansson, SL & Lin, M-F 2005, 'Expression of p66Shc protein correlates with proliferation of human prostate cancer cells', Oncogene, vol. 24, no. 48, pp. 7203-7212. https://doi.org/10.1038/sj.onc.1208852
Veeramani S, Igawa T, Yuan TC, Lin FF, Lee MS, Lin JS et al. Expression of p66Shc protein correlates with proliferation of human prostate cancer cells. Oncogene. 2005 Nov 3;24(48):7203-7212. https://doi.org/10.1038/sj.onc.1208852
Veeramani, Suresh ; Igawa, Tsukasa ; Yuan, Ta Chun ; Lin, Fen Fen ; Lee, Ming Shyue ; Lin, Jamie S. ; Johansson, Sonny L. ; Lin, Ming-Fong. / Expression of p66Shc protein correlates with proliferation of human prostate cancer cells. In: Oncogene. 2005 ; Vol. 24, No. 48. pp. 7203-7212.
@article{a19d6309d65a4282aaaf99eae5f39c56,
title = "Expression of p66Shc protein correlates with proliferation of human prostate cancer cells",
abstract = "p66Shc, an isoform of Shc adaptor proteins, is shown to mediate various signals, including cellular stress. However, little is known about its involvement in carcinogenesis. We previously showed that p66Shc protein level is upregulated by steroid hormones in human carcinoma cells and is higher in prostate cancer (PCa) specimens than adjacent noncancerous cells. In this study, we investigated the role of p66Shc protein in PCa cell proliferation. Among different PCa cell lines tested, p66Shc protein level showed positive correlation with cell proliferation, that is, rapid-growing cells expressed higher p66Shc protein than slow-growing cells. Exposure of slow-growing LNCaP C-33 cells to epidermal growth factor (EGF) and 5α-dihydrotestosterone (DHT) led to upregulation of proliferation and p66Shc protein level. Conversely, growth suppression of fast-growing cells by cellular form of prostatic acid phosphatase (cPAcP) expression, a negative growth regulator, downregulated their p66 Shc protein level. Additionally, increased expression of p66 Shc protein by cDNA transfection in LNCaP C-33 cells resulted in increased cell proliferation. Cell cycle analyses showed higher percentage of p66Shc-overexpressing cells at S phase (24{\%}) than control cells (17{\%}), correlating with their growth rates. On the other hand, transient knock-down of p66Shc expression by RNAi in rapidly growing cells decreased their proliferation as evidenced by the reduced cell growth as well as S phase in p66Shc-knocked down cells. The p66Shc signaling in cell growth regulation is apparently mediated by extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK). Thus, our results indicate a novel role for p66Shc in prostate carcinogenesis, in part, promoting cell proliferation.",
keywords = "Cell proliferation, Prostate cancer, Prostatic acid phosphatase, p66",
author = "Suresh Veeramani and Tsukasa Igawa and Yuan, {Ta Chun} and Lin, {Fen Fen} and Lee, {Ming Shyue} and Lin, {Jamie S.} and Johansson, {Sonny L.} and Ming-Fong Lin",
year = "2005",
month = "11",
day = "3",
doi = "10.1038/sj.onc.1208852",
language = "English (US)",
volume = "24",
pages = "7203--7212",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "48",

}

TY - JOUR

T1 - Expression of p66Shc protein correlates with proliferation of human prostate cancer cells

AU - Veeramani, Suresh

AU - Igawa, Tsukasa

AU - Yuan, Ta Chun

AU - Lin, Fen Fen

AU - Lee, Ming Shyue

AU - Lin, Jamie S.

AU - Johansson, Sonny L.

AU - Lin, Ming-Fong

PY - 2005/11/3

Y1 - 2005/11/3

N2 - p66Shc, an isoform of Shc adaptor proteins, is shown to mediate various signals, including cellular stress. However, little is known about its involvement in carcinogenesis. We previously showed that p66Shc protein level is upregulated by steroid hormones in human carcinoma cells and is higher in prostate cancer (PCa) specimens than adjacent noncancerous cells. In this study, we investigated the role of p66Shc protein in PCa cell proliferation. Among different PCa cell lines tested, p66Shc protein level showed positive correlation with cell proliferation, that is, rapid-growing cells expressed higher p66Shc protein than slow-growing cells. Exposure of slow-growing LNCaP C-33 cells to epidermal growth factor (EGF) and 5α-dihydrotestosterone (DHT) led to upregulation of proliferation and p66Shc protein level. Conversely, growth suppression of fast-growing cells by cellular form of prostatic acid phosphatase (cPAcP) expression, a negative growth regulator, downregulated their p66 Shc protein level. Additionally, increased expression of p66 Shc protein by cDNA transfection in LNCaP C-33 cells resulted in increased cell proliferation. Cell cycle analyses showed higher percentage of p66Shc-overexpressing cells at S phase (24%) than control cells (17%), correlating with their growth rates. On the other hand, transient knock-down of p66Shc expression by RNAi in rapidly growing cells decreased their proliferation as evidenced by the reduced cell growth as well as S phase in p66Shc-knocked down cells. The p66Shc signaling in cell growth regulation is apparently mediated by extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK). Thus, our results indicate a novel role for p66Shc in prostate carcinogenesis, in part, promoting cell proliferation.

AB - p66Shc, an isoform of Shc adaptor proteins, is shown to mediate various signals, including cellular stress. However, little is known about its involvement in carcinogenesis. We previously showed that p66Shc protein level is upregulated by steroid hormones in human carcinoma cells and is higher in prostate cancer (PCa) specimens than adjacent noncancerous cells. In this study, we investigated the role of p66Shc protein in PCa cell proliferation. Among different PCa cell lines tested, p66Shc protein level showed positive correlation with cell proliferation, that is, rapid-growing cells expressed higher p66Shc protein than slow-growing cells. Exposure of slow-growing LNCaP C-33 cells to epidermal growth factor (EGF) and 5α-dihydrotestosterone (DHT) led to upregulation of proliferation and p66Shc protein level. Conversely, growth suppression of fast-growing cells by cellular form of prostatic acid phosphatase (cPAcP) expression, a negative growth regulator, downregulated their p66 Shc protein level. Additionally, increased expression of p66 Shc protein by cDNA transfection in LNCaP C-33 cells resulted in increased cell proliferation. Cell cycle analyses showed higher percentage of p66Shc-overexpressing cells at S phase (24%) than control cells (17%), correlating with their growth rates. On the other hand, transient knock-down of p66Shc expression by RNAi in rapidly growing cells decreased their proliferation as evidenced by the reduced cell growth as well as S phase in p66Shc-knocked down cells. The p66Shc signaling in cell growth regulation is apparently mediated by extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK). Thus, our results indicate a novel role for p66Shc in prostate carcinogenesis, in part, promoting cell proliferation.

KW - Cell proliferation

KW - Prostate cancer

KW - Prostatic acid phosphatase

KW - p66

UR - http://www.scopus.com/inward/record.url?scp=27944483366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27944483366&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208852

DO - 10.1038/sj.onc.1208852

M3 - Article

C2 - 16170380

AN - SCOPUS:27944483366

VL - 24

SP - 7203

EP - 7212

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 48

ER -